Lisa French
EVP & Chief Commercial Officer · Keenova Therapeutics plc
- 2025
- Feb 27, 2026
- 2
Summary
Latest filing:
Lisa French has 2 SEC Form 4 filings on record going back to 2025, most recently on 27 February 2026.
Trading pattern
InsiderAlpha's records for Lisa French go back to 2025: 2 primary Form 4 filings, an average of 1.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Most active insiders across the market
Lisa French has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- Robert M. Williams Jr. - $192.63M in AVAH purchases and sales in the last 90 days
- Sean Lie - $192.09M in CBRS purchases and sales in the last 90 days
- August J. Troendle - $190.85M in MEDP purchases and sales in the last 90 days
- Mauad Bruno Sousa - $189.07M in AUGO purchases and sales in the last 90 days
- Nathan Blecharczyk - $188.66M in ABNB purchases and sales in the last 90 days
- Conifer Management, L.L.C. - $187.26M in GPI purchases and sales in the last 90 days
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Lisa French?
Lisa French is a corporate insider, tracked as EVP & Chief Commercial Officer. InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Lisa French last file a Form 4?
The most recent primary Form 4 on record is dated 27 February 2026, one of 2 filings going back to 2025.
Learn more
No Form 4 transactions on record for Lisa French yet.
Filings appear here automatically as they arrive from SEC EDGAR.